NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000023101

Registered date:15/07/2016

[F-18]FDG and [C-11]Acetate PET/CT study for refractory diseases

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedhematologic malignancies and refractory or recurrent malignancies
Date of first enrollment2016/07/29
Target sample size120
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)After intravenous administration of 3.7MBq/kg C-11 acetate, whole-body PET/CT is performed immediately. Subsequently, whole-body PET/CT is also performed 60 min after injection of 3.7MBq/kg F-18 FDG.

Outcome(s)

Primary OutcomeAccuracy to detect lesions
Secondary OutcomeInter- and intra-observer variability

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriai. serum glucose level greater than 200mg/dl ii. pregnancy or possible iii. patients can't demonstrate informed consent iv. early gastric cancer in which [F-18]FDG PET/CT isn't applicable for covered health insurance

Related Information

Contact

public contact
Name Ukihide Tateishi
Address 1-5-45, Yushima Japan 1138519
Telephone 03-5803-5311
E-mail ttisdrnm@tmd.ac.jp
Affiliation Tokyo Medical and Dental University Diagnostic Radiology
scientific contact
Name Ukihide Tateishi
Address 1-5-45, Yushima Japan
Telephone 03-5803-5311
E-mail ttisdrnm@tmd.ac.jp
Affiliation Tokyo Medical and Dental University Diagnostic Radiology